Some options in studying side effects of drugs taken during pregnancy Jørn Olsen COMMENTARY 16 December 2015 Pages: 1137 - 1139
Maternal obesity during pregnancy and cardiovascular development and disease in the offspring Romy Gaillard REVIEW Open access 16 September 2015 Pages: 1141 - 1152
Detection and investigation of temporal clusters of congenital anomaly in Europe: seven years of experience of the EUROCAT surveillance system Helen DolkMaria LoaneAlan Kelly PERINATAL EPIDEMIOLOGY Open access 04 April 2015 Pages: 1153 - 1164
Using scan statistics for congenital anomalies surveillance: the EUROCAT methodology Conor TeljeurAlan KellyHelen Dolk PERINATAL EPIDEMIOLOGY 31 May 2015 Pages: 1165 - 1173
Body mass index, gestational weight gain and fatty acid concentrations during pregnancy: the Generation R Study Aleksandra Jelena VidakovicVincent W. V. JaddoeRomy Gaillard PERINATAL EPIDEMIOLOGY Open access 14 December 2015 Pages: 1175 - 1185
Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study Anthony WemakorKaren CassonHelen Dolk PHARMACO-EPIDEMIOLOGY 07 July 2015 Pages: 1187 - 1198
Pre-gravid oral contraceptive use in relation to birth weight: a prospective cohort study Elizabeth E. HatchKristen A. HahnLauren A. Wise PHARMACO-EPIDEMIOLOGY 16 June 2015 Pages: 1199 - 1208
Prolonged second stage of labor is associated with low Apgar score Maria AltmanAnna SandströmOlof Stephansson OBSTETRIC EPIDEMIOLOGY 26 May 2015 Pages: 1209 - 1215
Case–control studies require appropriate population controls: an example of error in the SSRI birth defect literature Michael B. Bracken Letter to the Editor 30 October 2015 Pages: 1217 - 1218
Response to: Case–control studies require appropriate population controls: an example of error in the SSRI birth defect literature Helen DolkAnthony Wemakor REPLY 30 November 2015 Pages: 1219 - 1221
